Page last updated: 2024-10-21

vanilmandelic acid and Huntington Disease

vanilmandelic acid has been researched along with Huntington Disease in 2 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McNamee, B1
Kelvin, AS1
Turnbull, MJ1
Tourian, AY1

Trials

1 trial available for vanilmandelic acid and Huntington Disease

ArticleYear
Administration of 5-hydroxy-L-tryptophan to individuals with Huntington's chorea.
    Neurology, 1972, Volume: 22, Issue:11

    Topics: 5-Hydroxytryptophan; Adult; Brain; Evaluation Studies as Topic; Female; Humans; Huntington Disease;

1972

Other Studies

1 other study available for vanilmandelic acid and Huntington Disease

ArticleYear
Urinary excretion of some monoamines and metabolites in Huntington's chorea.
    Scottish medical journal, 1971, Volume: 16, Issue:5

    Topics: Acetates; Adult; Aged; Catecholamines; Epinephrine; Female; Histamine; Humans; Huntington Disease; H

1971